Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sheena Monahan"'
Autor:
Stephanie Jemielity, Jinyize J Wang, Ying Kai Chan, Asim A Ahmed, Wenhui Li, Sheena Monahan, Xia Bu, Michael Farzan, Gordon J Freeman, Dale T Umetsu, Rosemarie H Dekruyff, Hyeryun Choe
Publikováno v:
PLoS Pathogens, Vol 9, Iss 3, p e1003232 (2013)
Human T-cell Immunoglobulin and Mucin-domain containing proteins (TIM1, 3, and 4) specifically bind phosphatidylserine (PS). TIM1 has been proposed to serve as a cellular receptor for hepatitis A virus and Ebola virus and as an entry factor for dengu
Externí odkaz:
https://doaj.org/article/3e0b25be82fb4447a20dffe357f3ec19
Autor:
Victoria Smith, Erin Stefanutti, Roderich E. Schwarz, Sheena Monahan, Niranjan Awasthi, Margaret A. Schwarz, Amanda Mikels-Vigdal
Publikováno v:
Journal of Cellular and Molecular Medicine
Matrix metalloproteinase 9 (MMP9) is involved in the proteolysis of extracellular proteins and plays a critical role in pancreatic ductal adenocarcinoma (PDAC) progression, invasion and metastasis. The therapeutic potential of an anti‐MMP9 antibody
Publikováno v:
Oncotarget
Nab-paclitaxel (NPT) combination with gemcitabine (Gem) represents the standard chemotherapy for pancreatic ductal adenocarcinoma (PDAC). Genetic alterations of the RAS/RAF/MEK/ERK (MAPK) signaling pathway yielding constitutive activation of the ERK
Autor:
Roderich E. Schwarz, Sheena Monahan, Eric Zhang, Niranjan Awasthi, Margaret A. Schwarz, Meghan Grojean, Emily Scire
Publikováno v:
Oncotarget
// Niranjan Awasthi 1,5 , Emily Scire 2 , Sheena Monahan 1 , Meghan Grojean 3 , Eric Zhang 1 , Margaret A. Schwarz 4,5 and Roderich E. Schwarz 1,6 1 Department of Surgery, Indiana University School of Medicine, South Bend, IN, USA 2 Department of Che
Autor:
Urs von Holzen, Sheena Monahan, Meghan Grojean, Niranjan Awasthi, Sazzad Hassan, Roderich E. Schwarz, Margaret A. Schwarz
Publikováno v:
Cancer Research. 78:5807-5807
BACKGROUND: Gastric adenocarcinoma (GAC) is the fourth most common malignant tumor in the world. Several growth factors and their receptors including c-Met and VEGFR, are overexpressed in GAC and thus provide a potentially effective therapeutic targe
Autor:
Niranjan Awasthi, Victoria Smith, Erin Stefanutti, Amanda Mikels-Vigdal, Margaret A. Schwarz, Roderich E. Schwarz, Sheena Monahan
Publikováno v:
Cancer Research. 78:4822-4822
BACKGROUND: Matrix metalloproteinase 9 (MMP9) is involved in the proteolysis of extracellular proteins and is reported to play a key role in development, invasion and metastasis of many cancers including pancreatic ductal adenocarcinoma (PDAC). Andec
Publikováno v:
Molecular Cancer Therapeutics. 17:LB-B29
Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal cancer with mortality closely paralleling incidence despite substantial advances in biological understanding of the disease. Nab-paclitaxel (NPT) plus Gemcitabine (Gem) represents the cu
Publikováno v:
Cancer Research. 77:4202-4202
Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer related deaths in the USA with a 5-year survival less than 6%. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel, NPT) has demonstrated 8.5 months median survi
Autor:
Rosemarie H. DeKruyff, Sheena Monahan, Denis Bedoret, Dale T. Umetsu, Wan-Ling Lee, Sarah E. Umetsu, Lee A. Albacker, Gordon J. Freeman, Sanhong Yu
Publikováno v:
Mucosal immunology. 6(3)
Respiratory exposure to antigen induces T cell tolerance via several overlapping mechanisms that limit the immune response. While the mechanisms involved in the development of Treg cells have received much attention, those that result in T cell delet
Publikováno v:
Cancer Research. 76:276-276
Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis of all solid tumors, with an overall survival rate of less than 6%. Gemcitabine (Gem) remained the standard of care agent over the past 16 years despite limited clinical benefits. Nab-pa